Healthcare advertising increasingly depends on precision, compliance, and measurable engagement, particularly when campaigns target licensed medical professionals rather than general consumer audiences. PulsePoint’s latest expansion reflects that shift by bringing verified healthcare professional (HCP) audience activation to two of the industry’s most influential search platforms: Google Search and Microsoft Bing.
The healthcare advertising technology company announced that its Audience Manager platform now supports deterministic activation of verified National Provider Identifier (NPI)-level audiences across both search engines. The enhancement allows pharmaceutical brands to integrate search advertising with PulsePoint’s existing omnichannel ecosystem, creating a more unified approach to physician engagement.
Search remains one of the primary channels healthcare professionals use when researching treatment options, clinical guidelines, and pharmaceutical products. PulsePoint cites industry research indicating that more than 94% of healthcare professionals use search engines for pharmaceutical research, while search influences treatment decisions significantly more than emerging AI-powered research tools. That behavior makes search advertising an increasingly important component of pharmaceutical marketing strategies.
Traditional search advertising platforms, however, often rely on inferred audience segments or contextual signals rather than verified professional identities. For highly regulated healthcare campaigns, that limitation can create challenges around targeting accuracy, campaign measurement, and regulatory accountability.
PulsePoint addresses this through its DirectMatch™ technology, which enables marketers to identify and engage verified healthcare professionals using deterministic NPI-based identity resolution instead of probabilistic audience modeling. Rather than targeting broad professional categories, advertisers can activate campaigns against verified clinician audiences while maintaining greater transparency and auditability.
The expansion also strengthens campaign measurement. Audience Manager now provides Physician-Level Data (PLD) reporting, allowing marketers to analyze engagement at the individual NPI level across keywords, specialties, ad groups, and timestamps. For pharmaceutical advertisers operating under strict compliance requirements, this level of reporting supports more granular optimization while improving confidence in campaign performance.
Beyond search, PulsePoint positions the capability as part of a broader omnichannel strategy. The company’s platform enables healthcare marketers to coordinate audience engagement across display advertising, connected TV (CTV), audio, electronic health record (EHR) environments, and social media, helping brands maintain consistent messaging throughout the healthcare professional decision journey.
The announcement reflects broader changes in healthcare advertising technology, where advertisers increasingly prioritize verified first-party identity, deterministic targeting, and privacy-conscious measurement. As regulatory scrutiny grows and third-party identifiers become less reliable, healthcare marketers are investing in platforms capable of delivering precise audience verification while maintaining compliance with industry standards.
The move also highlights the continued importance of search advertising despite the rapid growth of generative AI. While conversational AI platforms are changing how consumers discover information, search engines remain a dominant source of professional medical research. Healthcare professionals frequently rely on structured search results, peer-reviewed resources, clinical guidelines, and approved pharmaceutical information during treatment evaluation, making search advertising a strategically valuable channel for life sciences companies.
According to eMarketer, healthcare and pharmaceutical organizations continue increasing investments in digital advertising as omnichannel engagement becomes central to physician outreach strategies. At the same time, Gartner identifies AI-powered marketing, advanced analytics, and first-party data activation as key priorities for enterprise marketing organizations seeking more measurable customer engagement.
The competitive landscape is also evolving. Companies such as Google, Microsoft, Adobe, and Amazon continue expanding AI-driven advertising capabilities, while specialized healthcare advertising platforms differentiate themselves through industry-specific identity infrastructure, compliance frameworks, and measurement technologies. PulsePoint’s focus on verified NPI-level targeting positions the company within this specialized segment of healthcare AdTech rather than the broader digital advertising market.
For pharmaceutical manufacturers and healthcare agencies, integrating verified physician targeting into search advertising may improve campaign efficiency while supporting more accurate attribution across increasingly complex media plans. Combining deterministic identity with omnichannel measurement also enables advertisers to understand how physician interactions across multiple channels contribute to engagement and prescribing outcomes.
As healthcare marketing becomes increasingly data-driven, platforms that integrate search advertising, identity resolution, audience verification, and cross-channel measurement are expected to play a larger role in pharmaceutical advertising strategies. PulsePoint’s latest expansion illustrates how healthcare-specific advertising technology continues evolving beyond media buying to deliver integrated infrastructure for precision marketing, compliance, and performance optimization.
Market Landscape
Healthcare advertising is moving toward deterministic identity, first-party data activation, and privacy-compliant measurement as pharmaceutical marketers seek greater accountability across digital channels. Search advertising remains a critical touchpoint for physician engagement, while omnichannel platforms increasingly connect search, display, connected TV, EHR systems, and analytics into unified campaign ecosystems.
Strategic Outlook
PulsePoint’s expansion into Google Search and Microsoft Bing signals growing demand for healthcare-specific advertising infrastructure that combines verified identity, cross-channel measurement, and regulatory compliance. As AI transforms digital marketing, specialized AdTech platforms offering deterministic targeting and physician-level analytics may become increasingly valuable for pharmaceutical brands seeking measurable omnichannel performance.
Top Insights
- PulsePoint extends verified NPI-level healthcare professional targeting to Google Search and Microsoft Bing, strengthening precision advertising for pharmaceutical marketers.
- DirectMatch™ enables deterministic physician identification, improving audience transparency and reducing reliance on inferred targeting methods.
- Physician-Level Data reporting provides detailed engagement insights by keyword, specialty, ad group, and timestamp to optimize campaigns.
- The expansion supports omnichannel healthcare advertising by connecting search campaigns with display, CTV, EHR, audio, and social media.
- Healthcare advertisers benefit from improved measurement, compliance, and attribution as digital physician engagement becomes increasingly data-driven.
Get in touch with our Adtech experts
